We examine provider responses to the expansion of public subsidies in 2015 for oral chemotherapy treatment, in a health system where providers were free to determine their own prices. Oral chemotherapy treatment was known to have similar efficacy to its traditional intravenous alternative and...

In this paper, we examine trends in provider fees charged, government expenditure on private out-of-hospital medical services, and out of pocket costs following policy changes intended to reduce government expenditure. We examine the experience of a high-need patient group: people diagnosed with...